OverviewSuggest Edit

ValenTx is an early-stage medical device company developing a non-surgical, implantable medical therapy to treat obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. It offers a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in least-invasive therapy.

Latest Updates

Employees (est.) (Sep 2019)16

ValenTx Financials and Metrics

Summary Metrics

Founding Date


ValenTx total Funding

$38.1 m

ValenTx latest funding size

$10.30 m

Time since last funding

a year ago

ValenTx investors

ValenTx's latest funding round in August 2018 was reported to be $10.3 m. In total, ValenTx has raised $38.1 m
Show all financial metrics

ValenTx Online and Social Media Presence

Embed Graph

ValenTx Frequently Asked Questions

  • When was ValenTx founded?

    ValenTx was founded in 2002.

  • How many employees does ValenTx have?

    ValenTx has 16 employees.

  • Who are ValenTx competitors?

    Competitors of ValenTx include Tactile Medical, E-Qure and Novian Health.